Filana Therapeutics earnings were -$42.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest FLNA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$8.6M, down 16.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FLNA reported annual earnings of -$91.0M, with 273.7% growth. The next FLNA earnings date is Aug 13, 2026.
Filana Therapeutics Earnings Reports & History FAQ
What were Filana Therapeutics's earnings last quarter?
On FLNA's earnings call on Aug 13, 2026, Filana Therapeutics (NASDAQ: FLNA) reported Q2 2026 earnings per share (EPS) of -$0.18, up 80.43% year over year. Total FLNA earnings for the quarter were -$8.60 million. In the same quarter last year, Filana Therapeutics's earnings per share (EPS) was -$0.92.
The next FLNA earnings call is Aug 13, 2026. Add FLNA to your watchlist to be reminded of Filana Therapeutics's next earnings date.
Is Filana Therapeutics profitable or losing money?
As of the last Filana Therapeutics earnings report, Filana Therapeutics is currently losing money. Filana Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$42.28 million, a 65.67% decrease year over year.
What was FLNA's earnings growth in the past year?
As of Filana Therapeutics's earnings date in Aug 13, 2026, Filana Therapeutics's earnings has grown year over year. FLNA earnings in the past year totalled -$42.28 million.
What are Filana Therapeutics's earnings expectations?
The current EPS estimate for Filana Therapeutics's earnings report in Aug 13, 2026 is -$0.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.